Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICE: Intravenous Thrombolysis in Acute Ischemic Stroke with Cancer
NCT06841965Phase 3Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Mar 2025
- Primary completion
- Jun 2027
- Modality
- Metabolic Enzymes
01
Overview
A Phase 3 trial of tissue-plasminogen activator, tenecteplase, reteplase, recombinant human prourokinase in ischemic stroke, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
tissue-plasminogen activatortenecteplasereteplaserecombinant human prourokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06841965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06841965.